Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Pheton Holdings Ltd (PTHL : NSDQ)

• Company Description    Pheton Holdings Ltd, through its wholly owned operating subsidiary, Beijing Feitian Zhaoye Technology Co., Ltd., focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its lead product includes Beijing Feitian's Treatment Planning System. Pheton Holdings Ltd is based in BEIJING, China. Number of Employees: 10

• Price / Volume Information    Yesterday's Closing Price: $21.01 Daily Weekly Monthly 20 Day Moving Average: 789,516 shares Shares Outstanding: 6.58 (millions) Market Capitalization: $138.29 (millions) Beta: 52 Week High: $22.34 52 Week Low: $1.32 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 21.51% 16.03% 12 Week 650.36% 533.24% Year To Date 376.42% 347.64%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL ROOM 306 NET BUILDING HONGJUNYING SOUTH RD CHAOYANG DISTRICT - BEIJING,F4 100012 CHN ph: 010-84817665 fax: - None http://www.ftzy.com.cn

• General Corporate Information    Officers Jianfei Zhang - Chief Executive Officer and Chairman Zhixin Li - Chief Financial Officer Pengfei Zhang - Director Edward C Ye - Director Swee Leng Seng - Director Peer Information Pheton Holdings Ltd (CHCR) Pheton Holdings Ltd (ESRX) Pheton Holdings Ltd (MYDP) Pheton Holdings Ltd (COR) Pheton Holdings Ltd (GBCS) Pheton Holdings Ltd (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: G71399102 SIC: 3845 Fiscal Year Fiscal Year End: December Last Reported Quarter: - Next Expected EPS Date: - Share - Related Items Shares Outstanding: 6.58 Most Recent Split Date: (:1) Beta: Market Capitalization: $138.29 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: -

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 22.36 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - - 03/31/25 - - 12/31/24 - - Current Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - 12.39 Quick Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - 12.17 Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - -142.63 Book Value 06/30/25 - - 03/31/25 - - 12/31/24 - 0.94 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - 0.85 Debt-to-Equity 06/30/25 - - 03/31/25 - - 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - - 03/31/25 - - 12/31/24 - 0.00

Powered by Zacks Investment Research ©